Financials data is unavailable for this security.
View more
Year on year Shanghai MicroPort Endovascular MedTech Group Co Ltd grew revenues 32.43% from 896.50m to 1.19bn while net income improved 37.98% from 356.88m to 492.43m.
| Gross margin | 74.51% |
|---|---|
| Net profit margin | 51.21% |
| Operating margin | 59.80% |
| Return on assets | 19.00% |
|---|---|
| Return on equity | 22.50% |
| Return on investment | 21.55% |
More ▼
Cash flow in CNYView more
In 2023, Shanghai MicroPort Endovascular MedTech Group Co Ltd increased its cash reserves by 204.26%, or 1.98bn. Cash Flow from Financing totalled 1.60bn or 134.88% of revenues. In addition the company generated 558.31m in cash from operations while cash used for investing totalled 177.09m.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 31.54 |
|---|---|
| Tangible book value per share | 23.15 |
More ▼
Balance sheet in CNYView more
| Current ratio | 6.01 |
|---|---|
| Quick ratio | 5.49 |
| Total debt/total equity | 0.0068 |
|---|---|
| Total debt/total capital | 0.0067 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 30.43% and 37.35%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
| Div yield(5 year avg) | 0.87% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 37.75% |
| EPS growth(5 years) | 32.31 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 31.31 |
More ▼
